Pharvaris (PHVS) Capital Expenditures Growth (1y) (2021 - 2026)
Pharvaris (PHVS) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Pharvaris |
28.66 Bn |
28.37 Bn |
- |
63.99% |
| Date | Value |
|---|
| Mar 31, 2026 |
63.99% |
| Dec 31, 2025 |
-61.00% |
| Sep 30, 2025 |
116.93% |
| Jun 30, 2025 |
-114.20% |
| Mar 31, 2025 |
-407.66% |
| Dec 31, 2024 |
499.66% |
| Sep 30, 2024 |
32.07% |
| Jun 30, 2024 |
-29.47% |
| Mar 31, 2024 |
-63.26% |
| Dec 31, 2023 |
776.27% |
| Sep 30, 2023 |
114,742,419.94% |
| Jun 30, 2023 |
-236,328,759.87% |
| Mar 31, 2023 |
30.96% |
| Dec 31, 2022 |
69.24% |
| Sep 30, 2022 |
-55.81% |
| Jun 30, 2022 |
11.85% |
| Mar 31, 2022 |
-143.79% |
| Dec 31, 2021 |
-798.37% |
| Sep 30, 2021 |
-63.73% |
| Jun 30, 2021 |
-520.78% |
